Clinical Trial

Infant Mortality Reduction by the Mass Administration of Azithromycin

Study acronym: MIRAMA
Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This trial will investigate the supplementation of azithromycin distribution to the "Child Health Days" platform in Burkina Faso for child mortality reduction. This distribution will pair door-to-door administration of vitamin A and azithromycin or placebo with acute malnutrition screening among children 1-11 months old.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2021-01-15; most recent amendment 2025-03-12.
Status change: Recruiting → Active, Not Recruiting 2025-01-15
Status change: Not Yet Recruiting → Recruiting 2022-03-21
Trial Details
NCT Number NCT04716712
Lead Sponsor University of California, San Francisco
Collaborators: Helen Keller International, Centre de Recherche en Sante de Nouna, Burkina Faso, Bill and Melinda Gates Foundation
Conditions Child Mortality
Enrollment 694,400 participants
Start Date 2021-10-04
Primary Completion 2025-01-30 (estimated)
Study Completion 2026-01-30 (estimated)
Updated on ClinicalTrials.gov 2025-03-13